7-15366183-T-C

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_001004320.2(AGMO):ā€‹c.1114A>Gā€‹(p.Ile372Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000304 in 1,609,338 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I372M) has been classified as Uncertain significance.

Frequency

Genomes: š‘“ 0.000039 ( 0 hom., cov: 33)
Exomes š‘“: 0.000030 ( 1 hom. )

Consequence

AGMO
NM_001004320.2 missense

Scores

19

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.26
Variant links:
Genes affected
AGMO (HGNC:33784): (alkylglycerol monooxygenase) The protein encoded by this gene is a tetrahydrobiopterin- and iron-dependent enzyme that cleaves the ether bond of alkylglycerols. Sequence comparisons distinguish this protein as forming a third, distinct class of tetrahydrobiopterin-dependent enzymes. Variations in this gene have been associated with decreased glucose-stimulated insulin response, type 2 diabetes, and susceptibility to intracranial aneurysms. [provided by RefSeq, Aug 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.065567404).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
AGMONM_001004320.2 linkuse as main transcriptc.1114A>G p.Ile372Val missense_variant 11/13 ENST00000342526.8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
AGMOENST00000342526.8 linkuse as main transcriptc.1114A>G p.Ile372Val missense_variant 11/131 NM_001004320.2 P1
AGMOENST00000407277.6 linkuse as main transcriptc.7A>G p.Ile3Val missense_variant 1/33
AGMOENST00000418075.1 linkuse as main transcriptc.40A>G p.Ile14Val missense_variant 1/33

Frequencies

GnomAD3 genomes
AF:
0.0000394
AC:
6
AN:
152098
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000621
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000652
AC:
16
AN:
245444
Hom.:
0
AF XY:
0.0000377
AC XY:
5
AN XY:
132620
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000584
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000336
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000272
Gnomad OTH exome
AF:
0.000166
GnomAD4 exome
AF:
0.0000295
AC:
43
AN:
1457240
Hom.:
1
Cov.:
30
AF XY:
0.0000262
AC XY:
19
AN XY:
724668
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000899
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000254
Gnomad4 SAS exome
AF:
0.000304
Gnomad4 FIN exome
AF:
0.0000188
Gnomad4 NFE exome
AF:
0.00000811
Gnomad4 OTH exome
AF:
0.0000332
GnomAD4 genome
AF:
0.0000394
AC:
6
AN:
152098
Hom.:
0
Cov.:
33
AF XY:
0.0000269
AC XY:
2
AN XY:
74300
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.000131
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000621
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000113
ExAC
AF:
0.0000906
AC:
11

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsApr 08, 2024The c.1114A>G (p.I372V) alteration is located in exon 11 (coding exon 11) of the AGMO gene. This alteration results from a A to G substitution at nucleotide position 1114, causing the isoleucine (I) at amino acid position 372 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.098
BayesDel_addAF
Benign
-0.37
T
BayesDel_noAF
Benign
-0.46
CADD
Benign
7.4
DANN
Benign
0.73
DEOGEN2
Benign
0.012
T;.
Eigen
Benign
-0.59
Eigen_PC
Benign
-0.48
FATHMM_MKL
Benign
0.70
D
LIST_S2
Benign
0.63
T;T
M_CAP
Benign
0.0036
T
MetaRNN
Benign
0.066
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.5
L;.
MutationTaster
Benign
0.99
N
PrimateAI
Benign
0.38
T
PROVEAN
Benign
-0.29
N;N
REVEL
Benign
0.10
Sift
Benign
0.46
T;T
Sift4G
Benign
0.35
T;T
Polyphen
0.0010
B;.
Vest4
0.34
MutPred
0.35
Gain of catalytic residue at I372 (P = 0.039);.;
MVP
0.10
MPC
0.0016
ClinPred
0.015
T
GERP RS
2.3
Varity_R
0.023
gMVP
0.47

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs776818252; hg19: chr7-15405808; API